These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

61 related items for PubMed ID: 4607363

  • 1. Xeroradiography for evaluating and analyzing nasal potency.
    Murgolo VJ, Bickham CE.
    Eye Ear Nose Throat Mon; 1974 Oct; 53(10):425-9. PubMed ID: 4607363
    [No Abstract] [Full Text] [Related]

  • 2. Histamine sensitivity in the nasal mucosa during four-week use of oxymetazoline.
    Graf P, Juto JE.
    Rhinology; 1994 Sep; 32(3):123-6. PubMed ID: 7839081
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of a new oxymetazoline preparation in the treatment of nasal congestion. A multicentre trial.
    Practitioner; 1975 May; 214(1283):685-688. PubMed ID: 49890
    [No Abstract] [Full Text] [Related]

  • 4. Paranasal sinusitis after long-term use of topical nasal decongestants.
    Min YG, Kim HS, Suh SH, Jeon SY, Son YI, Yoon S.
    Acta Otolaryngol; 1996 May; 116(3):465-71. PubMed ID: 8790749
    [Abstract] [Full Text] [Related]

  • 5. Vascular effects of topical oxymetazoline on human nasal mucosa.
    Bende M, Löth S.
    J Laryngol Otol; 1986 Mar; 100(3):285-8. PubMed ID: 3950497
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of different preparations of nasal decongestants on ciliary beat frequency in vitro.
    Deitmer T, Scheffler R.
    Rhinology; 1993 Dec; 31(4):151-3. PubMed ID: 7511251
    [Abstract] [Full Text] [Related]

  • 8. [Comparison between xylometazoline in a dosage spray and oxymetazoline in one dose pipettes].
    Petruson B, Ekedahl C, Geterud A, Aust R, Odkvist L.
    Lakartidningen; 1983 May 04; 80(18):1908-10. PubMed ID: 6350765
    [No Abstract] [Full Text] [Related]

  • 9. The nasal and bronchopulmonary effects of oxymetazoline and KB227.
    Carrillo L, Kishimoto T, Aviado DM.
    Ann Otol Rhinol Laryngol; 1969 Apr 04; 78(2):415-24. PubMed ID: 4180290
    [No Abstract] [Full Text] [Related]

  • 10. Effects of oxymetazoline on the ventilation of paranasal sinuses in healthy subjects.
    Paulsson B, Lindberg S, Ohlin P.
    Am J Rhinol; 2002 Apr 04; 16(2):125-9. PubMed ID: 12030359
    [Abstract] [Full Text] [Related]

  • 11. Management of benign red eye (evaluation of topical oxymetazoline--a double masked study).
    Vajpayee RB, Gupta SK, Angra SK, Uppal RK, Sharma YR, Mehta MR.
    Indian J Ophthalmol; 1986 Apr 04; 34(1):33-6. PubMed ID: 3443497
    [No Abstract] [Full Text] [Related]

  • 12. A comparative preference study between xylometazoline nasal dose spray (Otrivin) and oxymetazoline single-dose pipettes (Nezeril).
    Ekedahl C, Geterud A, Petruson B, Aust R, Odkvist L.
    Rhinology; 1983 Sep 04; 21(3):287-8. PubMed ID: 6195722
    [No Abstract] [Full Text] [Related]

  • 13. A new administration form of the nasal decongestant oxymetazoline: a study on the change of ostial patency in healthy individuals.
    Jannert M, Fryksmark U, Ackerhans M, Nilson K.
    Rhinology; 1994 Jun 04; 32(2):78-80. PubMed ID: 7939146
    [Abstract] [Full Text] [Related]

  • 14. Lack of effect on nasal discharge from a vasoconstrictor spray in common cold.
    Winther B, Brofeldt S, Borum P, Pedersen M, Mygind N.
    Eur J Respir Dis Suppl; 1983 Jun 04; 128 (Pt 2)():447-8. PubMed ID: 6194002
    [No Abstract] [Full Text] [Related]

  • 15. [Effect of locally administered oxymetazoline on intraocular pressure].
    Heilmann K, Goebel U.
    Ber Zusammenkunft Dtsch Ophthalmol Ges; 1975 Jun 04; (73):320-2. PubMed ID: 1242940
    [No Abstract] [Full Text] [Related]

  • 16. [Changes in the mucous membrane of the nose and paranasal sinuses in experimental animals under the effect of silo gas].
    Sobol' IM, Balandin AD.
    Vestn Otorinolaringol; 1971 Jun 04; 33(2):41-6. PubMed ID: 5120917
    [No Abstract] [Full Text] [Related]

  • 17. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
    Graf P.
    Rhinology; 1996 Mar 04; 34(1):9-13. PubMed ID: 8739860
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The distribution of nasal erectile mucosa as visualized by magnetic resonance imaging.
    Ng BA, Ramsey RG, Corey JP.
    Ear Nose Throat J; 1999 Mar 04; 78(3):159, 163-6. PubMed ID: 10188352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.